Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT is set to continue its positive trajectory, with over $2B of available liquidity and a strong track record in investments. Their recent forward equity issuance and ongoing active pipeline of deals indicate confidence in future growth opportunities. While regional headwinds may pose some risk, particularly in the skilled nursing housing segment, the company's solid balance sheet and strong performance in its integrated senior health campuses and outpatient medical segments provide a solid foundation for continued success.

Bears say

American Healthcare REIT is facing significant headwinds in the near-term due to higher G&A expenses, which are expected to offset any gains from increased NOI. Their SHOP segment has potential for upside if the summer leasing season performs strongly, but overall, their outlook for 2026 and 2027 is moderate. The company also has a basic ESG strategy, and given their current cost of capital and balance sheet, they will likely focus on acquiring their JV partner's Trilogy ownership stake and funding Trilogy related expansions or developments. However, there are several key risks, including a downturn in the healthcare industry and changes to regulations and supply pressures for skilled nursing and senior housing, that could negatively impact their performance in the future.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.